ASPREVA PHARMACEUTICALS REPORTS SECOND QUARTER 2005 RESULTS AND REVISES GUIDANCE
Aspreva Pharmaceuticals Corporation (NASDAQ: ASPV; TSX: ASV) today reported business and financial results for the second quarter ended June 30, 2005, highlighted by strong revenue performance and the company's first profitable quarter. Aspreva earned $1.2 million, or $0.03 per share, on revenue of $14.7 million. Unless otherwise specified, all amounts are in U.S. dollars and are reported under U.S. GAAP.
Canada NewsWire Group (http://www.newswire.ca/en/releases/archive/August2005/09/c8559.html)